Back to search
FDAFDA · Food and drugs·Recall number D-1058-2013

Bevacizumab 1.25 mg/0.05 mL PF, Avella Specialty Pharmacy, Phoenix, AZ, 85085, 877-782-7684

Published September 25, 2013 · Recall initiated: September 9, 2013

Summary

FDA records drug Class II recall D-1058-2013, published September 25, 2013 and initiated September 9, 2013. Recalling firm: Avella of Deer Valley, Inc.; Status: Terminated; Reported quantity: 750 units; Lot: 12-20130508@179, Exp 11/3/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Avella Specialty Pharmacy is recalling bevacizumab and vancomycin due to concerns of sterility assurance with the specialty pharmacy's independent testing laboratory.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Avella of Deer Valley, Inc.
Distributor
Nationwide and Puerto Rico
Lot
12-20130508@179, Exp 11/3/2013
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Bevacizumab 1.25 mg/0.05 mL PF, Avella Specialty Pharmacy, Phoenix, AZ, 85085, 877-782-7684 recalled?

Yes. FDA published recall D-1058-2013 on September 25, 2013. Reported hazard: Lack of Assurance of Sterility: Avella Specialty Pharmacy is recalling bevacizumab and vancomycin due to concerns of sterility assurance with the specialty pharmacy's independent testing laboratory.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release